![Jim Baker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jim Baker
Investor Relations Contact bij
DAMORA THERAPEUTICS, INC.
Profiel
Jim Baker is Chief Corporate Affairs Officer & Media Contact at Damora Therapeutics, Inc. since 2026.
Formerly, Mr. Baker was Executive Director-Corporate Affairs at Idera Pharmaceuticals, Inc. from 2014 to 2015 and Director-Corporate Communications at Sarepta Therapeutics, Inc. Education includes an undergraduate degree from the University of Southern California.
Actieve functies van Jim Baker
| Bedrijven | Functie | Begin |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Investor Relations Contact | 01-05-2026 |
Eerdere bekende functies van Jim Baker
| Bedrijven | Functie | Einde |
|---|---|---|
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Corporate Officer/Principal | - |
| SAREPTA THERAPEUTICS, INC. | Public Communications Contact | - |
Opleiding van Jim Baker
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
10
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
